ATP Inserted / Updated: ATP01/ATP01corr  This field indicates when an entry in Annex VI to CLP has been inserted and/or updated with an Adaptation to Technical Progress (ATP) to the CLP Regulation. CLP Classification (Table 3)
| |||||||||||||
ATP Inserted / Updated: ATP01/ATP01corr This field indicates when an entry in Annex VI to CLP has been inserted and/or updated with an Adaptation to Technical Progress (ATP) to the CLP Regulation. CLP Classification (Table 3)
| |||||||||||||
ATP Inserted / Updated: ATP01/ATP01corr This field indicates when an entry in Annex VI to CLP has been inserted and/or updated with an Adaptation to Technical Progress (ATP) to the CLP Regulation. CLP Classification (Table 3)
| |||||||||||||
ATP Inserted / Updated: ATP01/ATP01corr This field indicates when an entry in Annex VI to CLP has been inserted and/or updated with an Adaptation to Technical Progress (ATP) to the CLP Regulation. CLP Classification (Table 3)
| ||||||||||
ATP Inserted / Updated: ATP01/ATP01corr This field indicates when an entry in Annex VI to CLP has been inserted and/or updated with an Adaptation to Technical Progress (ATP) to the CLP Regulation. CLP Classification (Table 3)
| |||||||||||||
ATP Inserted / Updated: ATP01 This field indicates when an entry in Annex VI to CLP has been inserted and/or updated with an Adaptation to Technical Progress (ATP) to the CLP Regulation. CLP Classification (Table 3)
| ||||||||||
| EC / List no. EC: European Community number/ List no.: List number assigned by ECHA. List Numbers are purely technical identifiers for processing a submission via REACH-IT. More information: https://echa.europa.eu/information-on-chemicals/registered-substances/information | Name | CAS Number The CAS number associated with this substance in the EC Inventory and/or REACH-IT is reported here. In some cases, e.g. for differently hydrated forms of the same substance, alternative CAS numbers have been notified. In those cases, the additional CAS numbers are published in the column “additional notified information” below. |
|---|---|---|
| 231-556-4 | Sodium peroxometaborate | 7632-04-4 |
Notified classification and labelling according to CLP criteria
| Classification | Labelling | Specific Concentration limits, M-Factors | Notes | Classification affected by Impurities / Additives | Additional Notified Information | Number of Notifiers | Joint Entries | ||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Hazard Class and Category Code(s) | Hazard Statement Code(s) | Hazard Statement Code(s) | Supplementary Hazard Statement Code(s) | Pictograms, Signal Word Code(s) | |||||||
| Ox. Sol. 2 | H272 | H272 | GHS03 GHS08 GHS05 GHS07 Dgr | Repr. 1B; : C ≥ 9 % Repr. 1B; : 6.5 % ≤ C < 9 % Eye Dam. 1; : C ≥ 22 % Eye Irrit. 2; : 14 % ≤ C < 22 % | State/Form | 83 | View details | ||||
| Acute Tox. 4 | H302 | H302 | |||||||||
| Eye Dam. 1 | H318 | H318 | |||||||||
| STOT SE 3 | H335 | H335 | |||||||||
| Repr. 1B | H360 (Df) | H360 | |||||||||
| H272 | H272 | GHS03 GHS08 GHS05 GHS07 Dgr | Repr. 1A; : 6.5 % ≤ C < 9 % Repr. 1B; : C ≥ 9 % Eye Irrit. 2; : 14 % ≤ C < 22 % Eye Dam. 1; : C ≥ 22 % | State/Form | 36 | View details | |||||
| Acute Tox. 4 | H302 | H302 | |||||||||
| Eye Dam. 1 | H318 | H318 | |||||||||
| STOT SE 3 | H335 (Not applicable) | H335 | |||||||||
| Repr. 1B | H360 (May damage the ...) | H360 (May damage the ...) | |||||||||
| H272 | H272 | GHS03 GHS08 GHS05 GHS07 Dgr | Repr. 1B; : C ≥ 9 % Repr. 1B; : 6.5 % ≤ C < 9 % | State/Form | 19 | View details | |||||
| Acute Tox. 4 | H302 | H302 | |||||||||
| Eye Dam. 1 | H318 | H318 | |||||||||
| STOT SE 3 | H335 | H335 | |||||||||
| Repr. 1B | H360 (Df) | H360 (Df) | |||||||||
| H272 | H272 | GHS03 GHS08 GHS05 GHS07 Dgr | Repr. 1B; : 10 % ≤ C < 14 % Repr. 1B; : C ≥ 14 % | State/Form | 19 | View details | |||||
| Acute Tox. 4 | H302 | H302 | |||||||||
| Eye Dam. 1 | H318 | H318 | |||||||||
| Acute Tox. 4 | H332 | H332 | |||||||||
| STOT SE 3 | H335 | H335 | |||||||||
| Repr. 1B | H360 (Df) | H360 (Df) | |||||||||
| Eye Dam. 1 | H318 | H318 | GHS08 GHS05 GHS07 Dgr | 13 | View details | ||||||
| Acute Tox. 4 | H332 | H332 | |||||||||
| STOT SE 3 | H335 (respiratory tra...) | H335 | |||||||||
| Repr. 1B | H360 (Df) | H360 (Df: May damage ...) | |||||||||
| H272 | H272 | GHS03 GHS08 GHS05 GHS06 Dgr | Eye Dam. 1; : C ≥ 22 % Eye Irrit. 2; : 14 % ≤ C < 22 % Repr. 1B; : C ≥ 9 % Repr. 1B; : 6.5 % ≤ C < 9 % | State/Form | 7 | View details | |||||
| Acute Tox. 4 | H302 | H302 | |||||||||
| Eye Dam. 1 | H318 | H318 | |||||||||
| Acute Tox. 3 | H331 | H331 | |||||||||
| STOT SE 3 | H335 | H335 | |||||||||
| Repr. 1B | H360 (Df) | H360 (Df) | |||||||||
| Eye Dam. 1 | H318 | H318 | GHS08 GHS05 GHS07 Dgr | Repr. 1B; : C ≥ 14 % Repr. 1B; : 10 % ≤ C < 14 % | State/Form | 2 | View details | ||||
| STOT SE 3 | H335 | H335 | |||||||||
| Repr. 1B | H360 (Df) | H360 (Df) | |||||||||
| H272 | H272 | GHS03 GHS08 GHS05 GHS06 Dgr | Repr. 1B; : C ≥ 9 % Repr. 1B; : 6.5 % ≤ C < 9 % | State/Form | 2 | View details | |||||
| Acute Tox. 4 | H302 | H302 | |||||||||
| Eye Dam. 1 | H318 | H318 | |||||||||
| Acute Tox. 3 | H331 | H331 | |||||||||
| STOT SE 3 | H335 | H335 | |||||||||
| Repr. 1B | H360 (Df) | H360 (Df) | |||||||||
| Eye Dam. 1 | H318 | H318 | GHS08 GHS05 GHS07 Dgr | Repr. 1B; : 10 % ≤ C < 14 % Eye Dam. 1; : C ≥ 36 % Eye Irrit. 2; : 22 % ≤ C < 36 % Repr. 1B; : C ≥ 14 % | 1 | View details | |||||
| STOT SE 3 | H335 | H335 | |||||||||
| Repr. 1B | H360 (Df) | H360 (Df) | |||||||||
| Eye Dam. 1 | H318 | H318 | GHS08 GHS05 GHS07 Dgr | 1 | View details | ||||||
| STOT SE 3 | H335 (Affected organs) | H335 | |||||||||
| Repr. 1B | H360 | H360 | |||||||||
| H272 | H272 | GHS03 GHS08 GHS05 GHS07 Dgr | Repr. 1B; : C ≥ 9 % Repr. 1B; : 6.5 % ≤ C < 9 % |  | State/Form | 1 | View details | ||||
| Acute Tox. 4 | H302 | H302 | |||||||||
| Eye Dam. 1 | H318 | H318 | |||||||||
| STOT SE 3 | H335 | H335 | |||||||||
| Repr. 1B | H360 (Df) | H360 (Df) | |||||||||